Summary: Researchers have decoded how the brain’s most prevalent kainate receptor controls its ion channel. Focusing on the GluK2/GluK5 heteromer — a four-subunit complex composed of two GluK2 and two GluK5 proteins that together form a glutamate-activated ion channel — the team combined cryo-electron microscopy and rapid electrophysiology to reveal a surprising gating mechanism with clear implications for synaptic signaling and drug design.
High-resolution structures and fast patch-clamp recordings overturn a long-standing assumption: binding of a ligand exclusively to the two GluK5 subunits is sufficient to drive the shared channel pore into a persistently open, non-desensitizing state. That finding exposes a direct mechanical coupling between GluK5 and the pore-proximal GluK2 subunits and provides a precise structural target for therapeutics that modulate synaptic activity.
Key Facts
- The subunit puzzle: Ionotropic glutamate receptors (iGluRs) are tetramers in which each subunit contains an individual glutamate binding pocket. How binding events at individual subunits coordinate to open and close the central pore has been unclear.
- GluK5-driven activation: Contrary to expectations, ligand binding only at the GluK5 subunits can activate the GluK2/GluK5 receptor. Fast patch-clamp experiments using the GluK5-selective agonist 5-iodowillardiine showed that such selective occupancy can lock the channel in a continuously open state.
- Structural cross-talk: Cryo-EM structures reveal the mechanism: when a ligand occupies GluK5, it induces a mechanical shift in neighboring GluK2 subunits, which in turn opens the common ion channel pore despite GluK5’s less favorable positioning.
- Desensitization depends on occupancy: Partial ligand occupancy is sufficient for activation but does not trigger the large-scale rearrangement that produces receptor desensitization. Full occupancy of all four subunits is required to initiate the conformational collapse that inactivates the channel.
- Unique GluK5-GluK5 interface: The team identified a close interaction between opposing GluK5 subunits that is not observed in other kainate or AMPA receptor complexes, marking a distinct structural signature for GluK5-containing receptors.
- Slow deactivation explained: That specific GluK5-GluK5 contact correlates with an unusually slow deactivation rate for GluK2/GluK5 receptors — about ten times slower than many other kainate receptors — prolonging the receptor’s electrical response after stimulation.
- Physiological and therapeutic relevance: GluK2/GluK5 is the most abundant kainate receptor in human brain and mainly modulates synaptic activity. Because GluK2 and GluK5 differ in glutamate affinity, partially occupied receptor states that generate sustained, non-desensitizing currents may play important physiological roles and represent attractive targets for new neurological drugs.
Source: RUB
Background: The basic architecture of ionotropic glutamate receptors — four subunits assembling into a central pore and each contributing a ligand-binding domain — has been known for years. What remained unresolved is how ligand binding at individual subunits translates into coordinated movements that open, close, or desensitize the shared pore.
The research focused on the GluK2/GluK5 hetero-tetramer. Early experiments noted that selective activation of GluK5 was sufficient to open the receptor. Using fast patch-clamp recordings, one of the study’s first authors, Laura Moreno Wasielewski, demonstrated that 5-iodowillardiine — an agonist that preferentially binds GluK5 — drives these receptors into a persistently open configuration.
That result challenged prior assumptions because GluK2 subunits, located closer to the pore, were believed to be the primary drivers of gating. Cryo-electron microscopy performed in Joshua Levitz’s laboratory provided the structural explanation: GluK5 ligand binding displaces adjacent GluK2 domains in a way that forces the pore open, revealing long-range mechanical coupling between subunits.
The structures also clarified how desensitization is regulated. Partial ligand occupancy triggers activation but leaves the ligand-binding domain interfaces intact enough to avoid the conformational rupture that causes desensitization. Only when all four binding sites are occupied does the receptor undergo the interface disruption and large-scale rearrangement that silences the current.
A further unexpected finding was a tight contact between opposing GluK5 subunits. Electrophysiological follow-up showed this structural element contributes directly to the receptor’s slow deactivation — a kinetic property that can extend synaptic signals and shape temporal patterns of neuronal activity.
Function in the nervous system
The exact contribution of these biophysical properties to neural circuit function remains to be determined. GluK2/GluK5 receptors largely modulate synaptic transmission, and their sensitivity to partial ligand occupancy suggests they could support prolonged, non-desensitizing currents under physiological conditions. The newly identified GluK5-GluK5 interface gives researchers a concrete structural handle to explore how these prolonged responses affect synaptic signaling and behavior.
From a therapeutic standpoint, the distinctive features of GluK2/GluK5 receptors — differing subunit affinities, partial-occupancy activation, and a unique interaction site that slows deactivation — make this complex an appealing target for drugs designed to fine-tune synaptic modulation in neurological disorders.
Key Questions Answered:
A: Because GluK5 subunits sit in positions that seemed less directly coupled to the channel gate. The study shows that ligand occupancy of GluK5 produces a mechanical effect on nearby GluK2 subunits, which then open the pore.
A: Desensitization requires a full, four-site occupancy that breaks key ligand-binding domain interfaces. If only some sites are occupied — for example, only the GluK5 subunits — the receptor can remain active without undergoing the structural collapse that inactivates it, producing unusually long-lasting currents.
A: The discovery of a specific GluK5-GluK5 interaction that slows channel closing provides a unique structural target. Drugs that stabilize or disrupt this contact could selectively alter GluK2/GluK5 receptor kinetics and modulate synaptic activity with high specificity.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this neuroscience research news
Author: Meike Driessen
Source: RUB
Contact: Meike Driessen – RUB
Image: The image is credited to Neuroscience News
Original Research: Open access. “Structures of Partially Occupied Hetero-Tetramers Provide Insight Into Kainate Receptor Activation and Desensitizations” by Nandish K. Khanra, Alexa Strauss, Laura Moreno Wasielewski, Sophie Lenze, Joel Meyerson, Andreas Reiner & Joshua Levitz. Nature Communications. DOI: 10.1038/s41467-026-72226-w
Abstract
Structures of Partially Occupied Hetero-Tetramers Provide Insight Into Kainate Receptor Activation and Desensitization
Kainate receptors (KARs) are important regulators of synaptic transmission that rapidly activate and desensitize in response to glutamate. Under physiological and pharmacological conditions, agonist binding may occur at only a subset of sites within these tetramers. To understand how partial versus complete ligand occupancy affects function and conformation, the authors solved cryo-EM structures of the GluK2/GluK5 hetero-tetramer under partially occupied conditions using GluK5-selective agonists 5-iodowillardiine and AMPA.
High-resolution pre-active state structures, which include closed and open ligand-binding domain dimers with intact interfaces, reveal reshaping of gating-associated interfaces, coordinated motions between dimers, and repositioning of pore linkers in response to asymmetric agonist binding. Mutations at interfacial ligand-binding domain contacts — including a central cluster formed by GluK5 subunits and an inter-dimer contact between GluK2 and GluK5 — emphasize the role of LBD interactions in controlling receptor function and the distinct slow deactivation of GluK5-containing receptors.
The presence or absence of intact, partially ruptured, or fully ruptured LBD interfaces across ligand conditions supports a revised, stepwise model for ionotropic glutamate receptor activation and desensitization.